50 mg · vegan · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
5-Amino-1MQ is a peptide supplement that inhibits Nicotinamide N-methyltransferase (NNMT). It is researched for its potential role in modulating fat metabolism and improving metabolic markers. Available in capsule form, it is designed for adult use.
By inhibiting NNMT, 5-Amino-1MQ influences cellular energy pathways and NAD+ levels. This mechanism is studied for its impact on fat oxidation and glucose regulation, with effects on the pancreas, liver, and muscle tissue. Measurable metabolic changes typically emerge within 8-12 weeks of consistent use.
Adults looking to address insulin resistance, weight gain, low energy. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
C · C · emerging-to-moderate human evidence for metabolic and blood-sugar health
SacredBod's longer take on 5-Amino-1MQ — context the structured blocks above don't capture.
5-Amino-1MQ is a peptide supplement used to support metabolic and blood-sugar health. NNMT inhibitor researched for fat metabolism. It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. 5-Amino-1MQ works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the pancreas, liver, muscle, and effects are dose-dependent, typically becoming measurable within 8-12 weeks for metabolic markers. Consistency matters more than dose size for this category.
5-Amino-1MQ carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for metabolic and blood-sugar health. NNMT inhibitor researched for fat metabolism. Benefits are cumulative rather than immediate, typically becoming noticeable within 8-12 weeks for metabolic markers, and individual response varies.
A typical dose is 50 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Adults looking to address insulin resistance, weight gain, low energy. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Peptide category, 5-Amino-1MQ can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.
